- Previous Close
109.32 - Open
109.72 - Bid 43.51 x 1000
- Ask --
- Day's Range
107.89 - 110.33 - 52 Week Range
38.95 - 132.00 - Volume
339,750 - Avg. Volume
731,754 - Market Cap (intraday)
9.13B - Beta (5Y Monthly) 0.81
- PE Ratio (TTM)
9.22 - EPS (TTM)
11.80 - Earnings Date Feb 5, 2025 - Feb 10, 2025
- Forward Dividend & Yield 0.96 (0.88%)
- Ex-Dividend Date Jan 6, 2025
- 1y Target Est
132.20
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. It offers whole, term, and other life insurance products; Medicare supplement and supplemental health insurance products, such as accident, cancer, critical illness, heart, and intensive care plans; and single-premium and flexible-premium deferred annuities. The company sells its products through its direct to consumer division, exclusive agencies, and independent agents. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was founded in 1900 and is headquartered in McKinney, Texas.
www.home.globelifeinsurance.com3,636
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: GL
View MorePerformance Overview: GL
Trailing total returns as of 11/20/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: GL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: GL
View MoreValuation Measures
Market Cap
9.13B
Enterprise Value
11.76B
Trailing P/E
9.22
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.75
Price/Book (mrq)
1.97
Enterprise Value/Revenue
2.05
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
19.04%
Return on Assets (ttm)
3.31%
Return on Equity (ttm)
23.55%
Revenue (ttm)
5.73B
Net Income Avi to Common (ttm)
1.09B
Diluted EPS (ttm)
11.80
Balance Sheet and Cash Flow
Total Cash (mrq)
235.05M
Total Debt/Equity (mrq)
67.54%
Levered Free Cash Flow (ttm)
1.26B